Introduction
Tuberculosis in general is an important cause of morbidity and mortality worldwide. The largest number of cases occur in the South-East Asia Region, which accounts for one third of cases globally and the highest number of estimated deaths is in the South-East Asia Region 1 . An increase in the number of new cases in recent years has been attributed to the rapid spread of human immunodeficiency virus, development of drug resistant organisms and immigration from high prevalence countries.
Tuberculous meningitis was first described in 1836. It is a complex response by the central nervous system when infected by Mycobacterium tuberculosis, which includes cerebritis, abscess, tuberculoma and meningitis. The ba-SUMMARY -Forty-two patients diagnosed with tuberculous meningitis in Kuala Lumpur Hospital based on clinical criteria, cerebrospinal fluid analysis and response to antituberculous treatment over a seven year period were included in this study. Relevant information was obtained from patients' medical case notes and neuroimaging findings were evaluated. The clinical presentation of patients was staged according to Medical Research Council for tuberculous meningitis. Fisher's Exact Test was used to determine the correlation between the neuroimaging features, clinical staging and outcome of patients. 52.4% of patients had stage 2 disease, 28.6% stage 3 and the remainder stage 1 disease. 95.2% of patients had various neuroimaging abnormalities and only 4.8% had normal neuroimaging findings. The commonest neuroimaging findings were hydrocephalus and meningeal enhancement. 47.6% of patients survived without any complication. 23.8% developed morbidity either with minor or major neurological deficit and 28.6% had died at the end of the study period. Among patients with negative neuroimaging findings, one died and another one survived without any complication. Among patients with abnormal neuroimaging findings, 25% developed morbidity, 27.5% died and 47.5% survived without complication. The only neuroimaging feature significantly correlated with clinical outcome was the presence of hydrocephalus. Therefore, hydrocephalus is important in the prognosis of the disease and should be considered an indicator of poor clinical outcome. There was no significant correlation between clinical staging and clinical outcome, nor was there a significant correlation between clinical staging and individual neuroimaging features.
cilli reach the central nervous system by haematogenous spread forming small tuberculous lesions known as Rich's foci in the meninges, brain or spinal cord. The lesions can become localized tuberculous lesions as in tuberculoma or abscess, or they may rupture and contaminate the cerebrospinal fluid.
TBM may lead to a high, up to 69.9%, mortality rate 2 . Early commencement of chemotherapy leads to a favourable clinical response. Neuroimaging thus becomes one of the most important initial investigations in TBM, offering prompt and conclusive diagnosis, and allowing treatment to be given at an earlier stage. The majority of previous studies have evaluated neuroimaging features in a case study or case series. The aim of this study was to correlate the neuroimaging features of TBM with the clinical staging of the disease and the corresponding clinical outcome.
Methods and Materials
This study was carried out at the Diagnostic Imaging Department and Neurology Department of Kuala Lumpur Hospital. The study population included all TBM patients over the age of 12 years diagnosed over a seven year period, who underwent neuroimaging. The diagnosis of TBM was based on clinical criteria, cerebrospinal fluid analysis and a response to antituberculous treatment 3 . Relevant information was obtained from patients' medical case notes. Patients less than 12 years old and those with lost or incomplete medical records or imaging films were excluded from the study. Neuroimaging features were evaluated by neuroradiologists. The features included meningeal enhancement, hydrocephalus, infarction, enhancing lesions, presumed abscess, oedema and calcification. Patients were then staged according to the clinical findings and severity of illness on admission based on staging by the Medical Research Council 4 . Data were tabulated and analysed using Microsoft Excel and Statistical Package for Social Sciences (SPSS) version 11.0. Fisher's Exact Test was used in the analysis and the p value was set at 0.05 with confidence interval of 95%.
Results
This study comprised 42 subjects of whom 31 (73.8%) were male and 11 (26.2%) were female with a male to female ratio of 3:1. The three major ethnic groups in Malaysia (Malays, Chinese and Indians) and the immigrant group were represented in this study. The patients' ages ranged from 18 to 62 years old with a mean age of 34.4 years.
TBM patients were categorized into three different stages according to their clinical presentation upon admission. Based on these categories, most of the patients were in stage 2 (52.4%), followed by stage 3 (28.6%) and stage 1 (table 1) .
Neuroimaging features
On admission, only two patients (4.8%) had normal neuroimaging findings. The other 95.2% (n=40) presented with various neuroimaging features including at least one of the following: meningeal enhancement, hydrocephalus, infarction, cerebral oedema, enhancing lesion, calcification and abscess. 62% (n=26) of patients presented with hydrocephalus. An equal number of patients (n = 21) presented with and without meningeal enhancement. Out of these, 61.9% had enhancement of the basal cisterns, 42.9% had enhancement of the tentorium and 47.6% patients had meningeal enhancement involving other sites e.g. parietal lobe, temporal lobe, occipital lobe or Sylvian fissure. Involvement of multiple sites were seen in a number of patients.
Thirteen patients (30.9%) presented with enhancing lesions. Out of these, five were identified as tuberculomas. Thirteen patients (30.9%) presented with cranial nerve involvement, with six patients (14.2%) having multiple nerve involvement. The cranial nerves involved were the 3 rd , 4 th , 6 th and 7 th cranial nerves.
Infarction was seen in 28.6% (n=12) of patients. The size of infarction ranged from 0.5 to 4 cm. Most of the patients (n=9) presented with only a single infarction. The region of infarction included either one or both of the tha- Cerebral oedema was seen in 28.6% of patients (n=12). Abscess and calcification were seen in only 4.8% (n=2) of all cases.
Twenty-eight patients (66.7%) also had extrameningeal tuberculosis. Out of this group, 82.4% had concurrent pulmonary involvement. Two of the patients presented with spinal tuber-culosis, one with lymph node involvement and another two with involvement of other sites.
Clinical Staging and Outcome
In patients with negative neuroimaging findings, one died and another survived without any neurological deficit. In patients with see table 2 ). Overall, 47.6% of patients (n=20) survived without developing any complication. 23 .8% (n=10) ended up with some kind of morbidity either with minor or major neurological deficits. The other 12 patients, representing 28.6% of the study population, had died by the end of this study period. Figure 1 shows the distribution of patients according to clinical outcome during admission.
Most of the patients in stage 1 and 2 survived without developing complications. Morbidity was seen in 13.6% (n=3) of stage 2 patients and in only 12.5% (n=1) of the stage 1 patients. In contrast, 50% (n=6) of stage 3 patients developed neurological sequelae. 25% of stage 3 patients survived without complications and another 25% died during admission (see table 3 ). However the association between clinical staging and outcome was not found to be significant (Fisher's exact value=6.131, p >0.05).
As illustrated in table 4, hydrocephalus was the most common neuroimaging finding in all three stages, representing 11.9%, 33.3% and 16.7% of all subjects respectively. This is followed by meningeal enhancement. However, Fisher's Exact Test again revealed no associa-tion between neuroimaging features and clinical staging (p>0.05). Figure 2 summarizes the distribution of patients according to neuroimaging features and clinical outcome. In patients with hydrocephalus, 12 patients (46.1%) developed no complication, three patients (11.5%) developed morbidity and 11 patients (42.3%) died. In contrast, only 19.0% (n=4) of those with meningeal enhancement died, while 33.3% (n=7) developed morbidity and another 47.6% (n=10) survived without complications. Death was also noted in 33.3% (n=4) of patients with infarction.
Out of all the neuroimaging features, only hydrocephalus was noted to have a significant correlation with clinical outcome (Fisher exact test value 8.812, p=0.015). The remaining neuroimaging features did not show a significant correlation (p>0.05).
Discussion
Intracranial tuberculosis is a potentially lethal disease when it is not recognized. Early diagnosis and initiation of therapy is most important to prevent unnecessary morbidity and mortality. While tuberculosis continues to be an established threat in underdeveloped countries, there is a rising trend seen in the developed countries due to prevailing immigration patterns. This is further complicated by the rise in the incidence of human immunodefiency virus (HIV) infection as well as drug resistant organisms. Across all ages, tuberculous meningitis (TBM) is found to be a more frequent manifestation of neurotuberculosis than brain tuberculoma and is more frequently seen in children 5 . In this study, hydrocephalus was found to be the most consistent finding in all three disease stages. This finding is corroborated by other studies 6-10 documenting percentages ranging from 51.0 to 89.2%. Likewise, the percentage of hydrocephalus in this study was within the range and hydrocephalus was the sole neuroimaging feature in 23.8% (n=10) of the patients. This is caused by exudative material which is found in and around the interpeduncular fossa, then entering all basal arachnoid cisterns. This forms a constricting collar around the upper brain stem which effectively blocks the flow of CSF 11 . Late onset hydrocephalus is postulated to be due to fibrous tissue formation following resolution of basal exudate 12 . The presence of hydrocephalus has been related to a poor prognosis 13 . This is supported by our study showing that the morbidity and mortality rate in patients with hydrocephalus was 11.5% and 42.3% respectively. In our study, hydrocephalus is also the only neuroimaging feature showing a significant association with clinical outcome. Therefore, we postulate that the presence of hydrocephalus is important in disease prognosis and should be considered an indicator of poor clinical outcome. Recognizing this feature may help in making an early diagnosis and minimize any treatment delay, including patients requiring surgical intervention. A Figure 4 (A) FLAIR MRI images of a patient with tuberculous meningitis. Note the small areas of high signal consistent with tuberculomas. (B) The same patient in (A). The axial gadolinium enhanced image at the same level shows multiple small enhancing tuberculomas throughout the brain. Note that the gadolinium enhanced images are more sensitive for tuberculomas compared to the FLAIR images. (C) The same patient in 4 (A) and (B). The T1-weighted sagittal gadolinium enhanced image shows multiple tuberculomas throughout the brain.
B A C recent study by Zahra et Al 14 found that proper management of hydrocephalus is a significant prognostic factor in patients with TBM. Prognosis was notably worse in obstructive hydrocephalus and timely surgical intervention may be able to reverse the clinical outcome. This is also supported by another recent study which found that hydrocephalus is an indicator or a more severe disease, with a higher frequency of focal neurological signs and/or impaired consciousness 15 . The incidence of hydrocephalus also increases with the duration of illness 8 . TBM patients with initial hydrocephalus tend to have a delayed presentation 15 . The limitation in our study is that we did not take into account the duration of illness prior to hospital admission and neuroimaging. However, it was noted that the incidence of hydrocephalus was higher in Stage 2 and 3 disease, although no significant correlation was found.
Difficulty in establishing the diagnosis of TBM is well recognized, and in the absence of meningism, requires a high index of suspicion 16 . A timely diagnosis may be an obstacle for patients who are referred from other smaller hospitals. The lack of neuroimaging facilities in these hospitals may result in significant delays before lumbar puncture can be done. This would explain the higher incidences of Stage 2 and 3 disease by the time they are referred to our hospital.
Our study found that the clinical stage of the disease is not significantly correlated with clinical outcome. This finding was also found in another study which reviewed 61 patients 17 followed up after 12 months of treatment. However, it was noted that morbidity was seen in half of our patients in Stage 3 disease compared to 12.5% in Stage 1 and 13.6% in Stage 2.
Recent published studies have reported mortality rates below 35% (17) (18) (19) (20) . This is consistent with our findings, in which the mortality rate is 28.6%. However, the mortality rate was not significantly related to the stage of illness and this could be due to the small number of patients, similar to another recent study by Karstaedt et Al 2 . This particular study, however, noted a significant difference in mortality between those who were started on antituberculous treatment within 24 hours of admission and those whose treatment was delayed beyond 24 hours. In another study, prolonged duration of pre-existing symptoms and the female gender were found to be the predictors of neurological sequelae 21 . The time frame between the onset of symptoms and the commencement of treatment was not available in our study, which is a major limitation. Further research is needed to determine its correlation with the clinical staging and subsequent clinical outcome.
Conclusion
Hydrocephalus is the only neuroimaging feature significantly correlated with clinical outcome. Therefore, hydrocephalus is important in the prognostication of the disease and should be considered an indicator of poor clinical outcome. There is no significant correlation between the clinical staging and clinical outcome. There is also no significant correlation between the clinical staging and individual neuroimaging features.
